View in EDS HTML Full Text PDF Full Text

Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases.

Saved in:
Bibliographic Details
Title: Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases.
Authors: Mitchell J; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. jonathan.mitchell@astrazeneca.com., Camacho N; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Shea P; Institute for Genomic Medicine, Columbia University, New York, NY, USA., Stopsack KH; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA., Joseph V; Cancer Biology and Genetics Program, Sloan Kettering Institute, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Burren OS; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Dhindsa RS; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA., Nag A; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Berchuck JE; Dana-Farber Cancer Institute, Boston, MA, USA., O'Neill A; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Abbasi A; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Zoghbi AW; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA., Alegre-Díaz J; Faculty of Medicine, National Autonomous University of Mexico, Copilco Universidad, Coyoacán, Ciudad de México, Mexico., Kuri-Morales P; Faculty of Medicine, National Autonomous University of Mexico, Copilco Universidad, Coyoacán, Ciudad de México, Mexico.; Instituto Tecnológico y de Estudios Superiores de Monterrey, Tecnológico, Monterrey, Nuevo León, Mexico., Berumen J; Faculty of Medicine, National Autonomous University of Mexico, Copilco Universidad, Coyoacán, Ciudad de México, Mexico., Tapia-Conyer R; Faculty of Medicine, National Autonomous University of Mexico, Copilco Universidad, Coyoacán, Ciudad de México, Mexico., Emberson J; Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Torres JM; Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Collins R; Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Wang Q; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Waltham, MA, USA., Goldstein D; Institute for Genomic Medicine, Columbia University, New York, NY, USA., Matakidou A; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Haefliger C; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Anderson-Dring L; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., March R; Precision Medicine and Biosamples, R&D Oncology, AstraZeneca, Dublin, Ireland., Jobanputra V; Institute for Genomic Medicine, Columbia University, New York, NY, USA.; Department of Pathology and Cell Biology, Columbia University, New York, NY, USA., Dougherty B; Oncology R&D, AstraZeneca, Waltham, MA, USA., Carss K; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Petrovski S; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Kantoff PW; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Convergent Therapeutics, Cambridge, MA, USA., Offit K; Cancer Biology and Genetics Program, Sloan Kettering Institute, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA., Mucci LA; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; American Cancer Society, Atlanta, GA, USA., Pomerantz M; Dana-Farber Cancer Institute, Boston, MA, USA., Fabre MA; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. margarete.fabre@astrazeneca.com.; Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. margarete.fabre@astrazeneca.com.; Department of Haematology, University of Cambridge, Cambridge, UK. margarete.fabre@astrazeneca.com.
Source: Nature communications [Nat Commun] 2025 Feb 19; Vol. 16 (1), pp. 1779. Date of Electronic Publication: 2025 Feb 19.
Publication Type: Journal Article; Meta-Analysis
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39971927
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mitchell+J%22">Mitchell J</searchLink>; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. jonathan.mitchell@astrazeneca.com.<br /><searchLink fieldCode="AU" term="%22Camacho+N%22">Camacho N</searchLink>; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Shea+P%22">Shea P</searchLink>; Institute for Genomic Medicine, Columbia University, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Stopsack+KH%22">Stopsack KH</searchLink>; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Joseph+V%22">Joseph V</searchLink>; Cancer Biology and Genetics Program, Sloan Kettering Institute, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Burren+OS%22">Burren OS</searchLink>; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Dhindsa+RS%22">Dhindsa RS</searchLink>; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Nag+A%22">Nag A</searchLink>; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Berchuck+JE%22">Berchuck JE</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22O'Neill+A%22">O'Neill A</searchLink>; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Abbasi+A%22">Abbasi A</searchLink>; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Zoghbi+AW%22">Zoghbi AW</searchLink>; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Alegre-Díaz+J%22">Alegre-Díaz J</searchLink>; Faculty of Medicine, National Autonomous University of Mexico, Copilco Universidad, Coyoacán, Ciudad de México, Mexico.<br /><searchLink fieldCode="AU" term="%22Kuri-Morales+P%22">Kuri-Morales P</searchLink>; Faculty of Medicine, National Autonomous University of Mexico, Copilco Universidad, Coyoacán, Ciudad de México, Mexico.; Instituto Tecnológico y de Estudios Superiores de Monterrey, Tecnológico, Monterrey, Nuevo León, Mexico.<br /><searchLink fieldCode="AU" term="%22Berumen+J%22">Berumen J</searchLink>; Faculty of Medicine, National Autonomous University of Mexico, Copilco Universidad, Coyoacán, Ciudad de México, Mexico.<br /><searchLink fieldCode="AU" term="%22Tapia-Conyer+R%22">Tapia-Conyer R</searchLink>; Faculty of Medicine, National Autonomous University of Mexico, Copilco Universidad, Coyoacán, Ciudad de México, Mexico.<br /><searchLink fieldCode="AU" term="%22Emberson+J%22">Emberson J</searchLink>; Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Torres+JM%22">Torres JM</searchLink>; Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Collins+R%22">Collins R</searchLink>; Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Wang+Q%22">Wang Q</searchLink>; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Waltham, MA, USA.<br /><searchLink fieldCode="AU" term="%22Goldstein+D%22">Goldstein D</searchLink>; Institute for Genomic Medicine, Columbia University, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Matakidou+A%22">Matakidou A</searchLink>; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Haefliger+C%22">Haefliger C</searchLink>; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Anderson-Dring+L%22">Anderson-Dring L</searchLink>; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22March+R%22">March R</searchLink>; Precision Medicine and Biosamples, R&D Oncology, AstraZeneca, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Jobanputra+V%22">Jobanputra V</searchLink>; Institute for Genomic Medicine, Columbia University, New York, NY, USA.; Department of Pathology and Cell Biology, Columbia University, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Dougherty+B%22">Dougherty B</searchLink>; Oncology R&D, AstraZeneca, Waltham, MA, USA.<br /><searchLink fieldCode="AU" term="%22Carss+K%22">Carss K</searchLink>; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Petrovski+S%22">Petrovski S</searchLink>; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Kantoff+PW%22">Kantoff PW</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Convergent Therapeutics, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Offit+K%22">Offit K</searchLink>; Cancer Biology and Genetics Program, Sloan Kettering Institute, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Mucci+LA%22">Mucci LA</searchLink>; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; American Cancer Society, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Pomerantz+M%22">Pomerantz M</searchLink>; Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Fabre+MA%22">Fabre MA</searchLink>; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. margarete.fabre@astrazeneca.com.; Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. margarete.fabre@astrazeneca.com.; Department of Haematology, University of Cambridge, Cambridge, UK. margarete.fabre@astrazeneca.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2025 Feb 19; Vol. 16 (1), pp. 1779. <i>Date of Electronic Publication: </i>2025 Feb 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Meta-Analysis
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39971927
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-025-56944-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1779
    Titles:
      – TitleFull: Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mitchell J
      – PersonEntity:
          Name:
            NameFull: Camacho N
      – PersonEntity:
          Name:
            NameFull: Shea P
      – PersonEntity:
          Name:
            NameFull: Stopsack KH
      – PersonEntity:
          Name:
            NameFull: Joseph V
      – PersonEntity:
          Name:
            NameFull: Burren OS
      – PersonEntity:
          Name:
            NameFull: Dhindsa RS
      – PersonEntity:
          Name:
            NameFull: Nag A
      – PersonEntity:
          Name:
            NameFull: Berchuck JE
      – PersonEntity:
          Name:
            NameFull: O'Neill A
      – PersonEntity:
          Name:
            NameFull: Abbasi A
      – PersonEntity:
          Name:
            NameFull: Zoghbi AW
      – PersonEntity:
          Name:
            NameFull: Alegre-Díaz J
      – PersonEntity:
          Name:
            NameFull: Kuri-Morales P
      – PersonEntity:
          Name:
            NameFull: Berumen J
      – PersonEntity:
          Name:
            NameFull: Tapia-Conyer R
      – PersonEntity:
          Name:
            NameFull: Emberson J
      – PersonEntity:
          Name:
            NameFull: Torres JM
      – PersonEntity:
          Name:
            NameFull: Collins R
      – PersonEntity:
          Name:
            NameFull: Wang Q
      – PersonEntity:
          Name:
            NameFull: Goldstein D
      – PersonEntity:
          Name:
            NameFull: Matakidou A
      – PersonEntity:
          Name:
            NameFull: Haefliger C
      – PersonEntity:
          Name:
            NameFull: Anderson-Dring L
      – PersonEntity:
          Name:
            NameFull: March R
      – PersonEntity:
          Name:
            NameFull: Jobanputra V
      – PersonEntity:
          Name:
            NameFull: Dougherty B
      – PersonEntity:
          Name:
            NameFull: Carss K
      – PersonEntity:
          Name:
            NameFull: Petrovski S
      – PersonEntity:
          Name:
            NameFull: Kantoff PW
      – PersonEntity:
          Name:
            NameFull: Offit K
      – PersonEntity:
          Name:
            NameFull: Mucci LA
      – PersonEntity:
          Name:
            NameFull: Pomerantz M
      – PersonEntity:
          Name:
            NameFull: Fabre MA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 02
              Text: 2025 Feb 19
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1